公开(公告)号：US20190160709A1

公开(公告)日：2019-05-30

申请号：US16204935

申请日：2018-11-29

申请人： Eric Benjamin Martinez

发明人： Eric Benjamin Martinez

IPC分类号： B29B17/00

摘要： Techniques for converting plastic bags to a recyclable form are described. In some implementations, a device includes an outer container having an outer lid, an inner container situated within the outer container having an opening, and one or more heating elements. The inner container has an inner lid configured to cover the inner container's opening, and the outer lid of the outer container is configured to close over the inner lid. In response to a user input to the device, a conversion cycle is initiated in which electric power is supplied to one or more heating elements so that the one or more heating elements raise the inner container's internal temperature to a target temperature and maintain the inner container's internal temperature at a minimum of the target temperature for a predetermined conversion time sufficient to convert one or more plastic bags within the inner container to a recyclable plastic block.

公开(公告)号：US20060183766A1

公开(公告)日：2006-08-17

申请号：US11352726

申请日：2006-02-13

申请人： Joseph Boni ,  Muhammad Ashraf ,  Eric Benjamin

发明人： Joseph Boni ,  Muhammad Ashraf ,  Eric Benjamin

IPC分类号： A61K31/4745

CPC分类号： A61K9/2095 ,  A61K9/146 ,  A61K9/2027 ,  A61K31/4745

摘要： A CCI-779 oral dosage form is provided in which, after oral administration to a subject, the CCI-779 has a whole blood peak concentration (Cmax) of 5.4±1.8 ng/mL and an area under the curve (AUC) of about 66±about 22 ng-hr/ml and the sirolimus has a Cmax of 18.7±9.6 ng/mL and an AUC of about 600±about 228 ng-hr/ml, for a 25 mg unit dose of CCI-779. Another CCI-779 oral dosage form is provided which, after oral administration thereof to a subject, the CCI-779 has a Cmax of 5.7±1.7 ng/mL and an AUC of about 60±about 20 ng-hr/ml and the sirolimus has a Cmax of 17.1±8.1 ng/mL and an AUC of about 548±about 187 ng-hr/ml in whole blood, for a 25 mg unit dose of CCI-779. Products containing these oral dosage forms, and methods of use thereof, are also described.

摘要翻译： 提供CCI-779口服剂型，其中口服给予受试者后，CCI-779具有5.4±1.8ng / mL的全血峰浓度（C max）和面积 在约66±约22ng-hr / ml的曲线（AUC）下，西罗莫司的C max最大值为18.7±9.6ng / mL，AUC为约600±约228ng-hr / ml，用于25mg单位剂量的CCI-779。 提供了另一种CCI-779口服剂型，其在口服给予受试者后，CCI-779的C max≥5.7±1.7ng / mL，AUC为约60±20 ng-hr / ml，并且西罗莫司在全血中的C max最大值为17.1±8.1ng / mL，AUC为约548±约187ng-hr / ml，对于25mg单位剂量 的CCI-779。 还描述了含有这些口服剂型的产品及其使用方法。

公开(公告)号：US06978264B2

公开(公告)日：2005-12-20

申请号：US10037993

申请日：2002-01-03

申请人： Raman Chandrasekar ,  James Charles Finger, II ,  Sally K. Salas ,  Eric Benjamin Watson

发明人： Raman Chandrasekar ,  James Charles Finger, II ,  Sally K. Salas ,  Eric Benjamin Watson

IPC分类号： G06F17/30

CPC分类号： G06F17/30864 ,  Y10S707/99933

摘要： A search and a browse on a single user query is performed. A refined query is selected from the results of the first user query. Thereafter, a list of concepts from a first directory associated with the refined query is obtained. The concepts are defined in a hierarchical relationship with concepts having broader scope being higher in the hierarchy and concepts having a narrower scope being lower in the hierarchy. Additionally, a list of web sites associated with the search concept is obtained from a second directory.

摘要翻译： 执行单个用户查询的搜索和浏览。 从第一个用户查询的结果中选择精确的查询。 此后，获得与精简查询相关联的第一目录的概念列表。 这些概念以层次关系定义，而层次结构中具有较宽范围的概念和层次结构中较窄范围较窄的概念。 此外，从第二目录获得与搜索概念相关联的网站的列表。

公开(公告)号：US20050142192A1

公开(公告)日：2005-06-30

申请号：US10961871

申请日：2004-10-08

申请人： Eric Benjamin ,  William Cloud ,  Muhammad Ashraf ,  Mohammed Islam ,  Michael Brandt ,  Gerald Tremblay

发明人： Eric Benjamin ,  William Cloud ,  Muhammad Ashraf ,  Mohammed Islam ,  Michael Brandt ,  Gerald Tremblay

IPC分类号： A61K31/55 ,  A61K31/675 ,  A61K9/20

CPC分类号： A61K31/55

摘要： Solid, pharmaceutical dosage forms of [2-(8,9-dioxo-2,6-diazabicyclo [5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and derivatives thereof are disclosed. In addition, methods of use are disclosed for the treatment, inter alia, of cerebral vascular disorders, anxiety disorders; mood disorders; schizophrenia; schizophreniform disorder; schizoaffective disorder; cognitive impairment; chronic neurodegenerative disorders; inflammatory diseases; fibromyalgia; complications from herpes zoster; prevention of tolerance to opiate analgesia; withdrawal symptoms from addictive drugs; and pain.

摘要翻译： 公开了[2-（8,9-二氧代-2,6-二氮杂双环[5.2.0]壬-1（7） - 烯-2-基）烷基]膦酸及其衍生物的固体药物剂型。 此外，公开了使用方法用于治疗，特别是脑血管疾病，焦虑症; 情绪障碍; 精神分裂症 精神分裂症 分裂情感障碍; 认知障碍; 慢性神经变性疾病; 炎性疾病; 纤维肌痛; 带状疱疹并发症; 预防鸦片镇痛的耐受性; 戒毒症状来自上瘾药物; 和痛苦。

公开(公告)号：US4782047A

公开(公告)日：1988-11-01

申请号：US866171

申请日：1986-05-22

申请人： Eric Benjamin ,  Shabbir Anik ,  Ya-Yun T. Lin

发明人： Eric Benjamin ,  Shabbir Anik ,  Ya-Yun T. Lin

IPC分类号： A61K9/00 ,  A61K9/08 ,  A61K9/10 ,  A61K31/57 ,  A61K31/58 ,  A61K47/10 ,  A61K47/32 ,  A61K47/34 ,  A61P27/16 ,  A61P29/00 ,  A61K31/56

CPC分类号： A61K9/0043 ,  A61K31/57 ,  A61K31/58

摘要： A non-stinging aqueous anti-inflammatory steroid formulation suitable for intranasal administration comprises: an anti-inflammatory steroid in an amount between about 0.01% and about 0.05% (w/v); propylene glycol in an amount between about 2% and about 10% (w/v); PEG 400 in an amount between about 10% and about 25% (w/v); polysorbate 20 in an amount between about 1% and about 4% (w/v); an effective amount of a preservative; an effective amount of a stabilizer; an effective amount of an antioxidant; water; and pH buffering agent sufficient to adjust the pH of the resulting solution to between about 3.5 and about 7.

摘要翻译： 适用于鼻内给药的非刺激性抗炎类固醇制剂包括：约0.01％至约0.05％（w / v）之间的抗炎类固醇; 量为约2％至约10％（w / v）的丙二醇; 量为约10％至约25％（w / v）的PEG 400; 量为约1％至约4％（w / v）的聚山梨醇酯20; 有效量的防腐剂; 有效量的稳定剂; 有效量的抗氧化剂; 水; 和足以将所得溶液的pH调节至约3.5至约7的pH缓冲剂。

公开(公告)号：US08693699B2

公开(公告)日：2014-04-08

申请号：US13056251

申请日：2009-07-29

申请人： Matthew Fellers ,  Grant Davidson ,  Rongshan Yu ,  Eric Benjamin ,  Kenneth Gundry

发明人： Matthew Fellers ,  Grant Davidson ,  Rongshan Yu ,  Eric Benjamin ,  Kenneth Gundry

IPC分类号： H03B29/00

CPC分类号： H04R3/04 ,  G10K11/178 ,  G10K2210/1081 ,  G10K2210/30232 ,  H04R1/1083 ,  H04R2430/03

摘要： An electroacoustic channel soundfield is altered. An audio signal is applied by an electromechanical transducer to an acoustic space, causing air pressure changes therein. Another audio signal is obtained by a second electromechanical transducer, responsive to air pressure changes in the acoustic space. A transfer function estimate of the electroacoustic channel is established, responsive to the second audio signal and part of the first audio signal. The transfer function estimate is derived to be adaptive to temporal variations in the electroacoustic channel transfer function. Filters are obtained with transfer functions based on the transfer function estimate. Part of the first audio signal is filtered therewith.

摘要翻译： 改变电声通道声场。 音频信号由机电换能器施加到声学空间，导致其中的气压变化。 另一个音频信号是通过响应于声学空间中的气压变化的第二机电换能器获得的。 响应于第二音频信号和第一音频信号的一部分，建立电声通道的传递函数估计。 导出传递函数估计是适应于电声通道传递函数中的时间变化。 基于传递函数估计的传递函数获得滤波器。 第一音频信号的一部分被滤波。

公开(公告)号：US20080045455A1

公开(公告)日：2008-02-21

申请号：US11789637

申请日：2007-04-25

申请人： Adnan Mjalli ,  Robert Rothlein ,  Ye Tian ,  Jeffrey Webster ,  Eric Benjamin

发明人： Adnan Mjalli ,  Robert Rothlein ,  Ye Tian ,  Jeffrey Webster ,  Eric Benjamin

IPC分类号： A61K38/16 ,  A61P19/10 ,  A61P25/28 ,  A61P29/00 ,  A61P3/10 ,  A61P37/00 ,  C07H21/04 ,  C07K14/00 ,  C12N15/00 ,  C12N15/09

CPC分类号： C07K14/70503 ,  A61K38/00 ,  C07K2319/30 ,  C12N15/62

摘要： Disclosed are RAGE fusion proteins comprising RAGE polypeptide sequences linked to a second, non-RAGE polypeptide. The RAGE fusion protein may utilize a RAGE polypeptide domain comprising a RAGE ligand binding site and an interdomain linker directly linked to the N-terminus of an immunoglobulin CH2 domain. Also disclosed are RAGE fusion protein formulations and the use of the RAGE fusion proteins and RAGE fusion protein formulations as therapeutics for RAGE-mediated pathologies.

摘要翻译： 公开了包含与第二非RAGE多肽连接的RAGE多肽序列的RAGE融合蛋白。 RAGE融合蛋白可以利用包含RAGE配体结合位点的RAGE多肽结构域和直接连接到免疫球蛋白C H 2结构域的N末端的域间连接体。 还公开了RAGE融合蛋白制剂以及使用RAGE融合蛋白和RAGE融合蛋白制剂作为RAGE介导的病理学的治疗剂。

公开(公告)号：US20070277097A1

公开(公告)日：2007-11-29

申请号：US11420443

申请日：2006-05-25

申请人： Erik Frederick Hennum ,  John P. Hunt ,  Matthew Paul Laroche ,  Eric Benjamin Munson ,  Goss Franklin Nuzzo-Jones

发明人： Erik Frederick Hennum ,  John P. Hunt ,  Matthew Paul Laroche ,  Eric Benjamin Munson ,  Goss Franklin Nuzzo-Jones

IPC分类号： G06F17/00

CPC分类号： G06F17/2264 ,  G09B5/00 ,  G09B7/00

摘要： An computer program product, a system, and method are disclosed for providing a training service. Delivery of the training service comprises selecting an input file comprising a plurality of presentation options, a plurality of mode definitions and a transform module. The transform module comprises transform logic configured to act upon content of an input file to present the input file to a user differently according to characteristics of a selected mode definition. Delivery of the training service further comprises receiving an input file selection and a mode definition selection. In addition, the transform module dynamically generates an output format for presentation of the content of the input file. The output format is generated by the transform logic as determined by the characteristics of the selected mode definition.

摘要翻译： 公开了用于提供训练服务的计算机程序产品，系统和方法。 训练服务的传送包括选择包括多个呈现选项，多个模式定义和变换模块的输入文件。 变换模块包括变换逻辑，其被配置为根据输入文件的内容进行操作，以根据所选择的模式定义的特征将输入文件呈现给用户。 训练服务的传送还包括接收输入文件选择和模式定义选择。 此外，变换模块动态地生成用于呈现输入文件的内容的输出格式。 输出格式由所选择的模式定义的特性确定的变换逻辑生成。

公开(公告)号：US20070082952A1

公开(公告)日：2007-04-12

申请号：US11544362

申请日：2006-10-06

申请人： Eric Benjamin

发明人： Eric Benjamin

IPC分类号： A61K31/195

CPC分类号： A61K31/166 ,  A61K9/1617 ,  A61K9/1652 ,  A61K9/2013 ,  A61K9/2018 ,  A61K9/2054 ,  A61K9/4866

摘要： The present invention provides compositions, useful as pharmaceuticals, comprising 3-biphenyl-4-yl-(2S)-[(4′-trifluoromethyl-biphenyl-4-carbonyl)-amino]-propionic acid. Also disclosed are methods for preparing the compositions and methods for using the compositions.

摘要翻译： 本发明提供可用作药物的组合物，其包含3-联苯-4-基 - （2S） - [（4'-三氟甲基 - 联苯-4-羰基） - 氨基] - 丙酸。 还公开了制备组合物的方法和使用该组合物的方法。

公开(公告)号：US06574644B2

公开(公告)日：2003-06-03

申请号：US08979434

申请日：1997-11-26

申请人： Liang-Hua Hsu ,  Russell Eric Benjamin Johnson-Laird

发明人： Liang-Hua Hsu ,  Russell Eric Benjamin Johnson-Laird

IPC分类号： G06F1500

CPC分类号： G06F17/30882 ,  G06F17/3089

摘要： A system of hyperlink authoring allows authors to establish links in multimedia documents interactively and provides generalization and specialization mechanisms for transforming the content and context of the instances of links indicated by the authors into more general link rules that when executed can automatically generate a large number of syntactically similar links. A major component of the system, the link editor, comprises specifications for the source, the intermediate destination, if required, and the final destination. Each specification comprises content pattern generalization, pattern variable instantiation, attribute modification, context specialization and attribute variable instantiation. The output of the link editor is link specifications which are forwarded to an automatic hyperlinker which outputs linked documents.

摘要翻译： 超链接创作系统允许作者以交互方式建立多媒体文件中的链接，并提供泛型和专业化机制，将作者指出的链接实例的内容和上下文变换为更一般的链接规则，当执行时可以自动生成大量 语法上类似的链接。 系统的主要组成部分，链接编辑器，包括源，中间目的地（如果需要）和最终目的地的规范。 每个规范包括内容模式概括，模式变量实例化，属性修改，上下文专业化和属性变量实例化。 链接编辑器的输出是将链接规范转发到自动超链接器，该自动超级链接器输出链接的文档。